Atlizumab or tocilizumab
- Level
- Commodity
- Parent
- 51201500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51201569This classification denotes a monoclonal antibody with the molecular formula C6428H9976N1720O2018S42, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I031V2H011, more generally known as tocilizumab. European Medicines Agency schedules tocilizumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20313. The term TOCILIZUMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 18, no. 3, 2004, list 52. Atlizumab or tocilizumab bears US NLM identifiers UMLS ID C1609165 and NCI Concept Code C84217.
Same parent
Under 51201500 · 15Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.